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Background: To determine if black-blood 3 T cardiovascular magnetic resonance (bb-CMR) can depict differences
between symptomatic and asymptomatic carotid atherosclerotic plaques in acute ischemic stroke patients.
Methods: In this prospective monocentric observational study 34 patients (24 males; 70 ±9.3 years) with
symptomatic carotid disease defined as ischemic brain lesions in one internal carotid artery territory on diffusion
weighted images underwent a carotid bb-CMR at 3 T with fat-saturated pre- and post-contrast T1w-, PDw-,
T2w- and TOF images using surface coils and Parallel Imaging techniques (PAT factor = 2) within 10 days after
symptom onset. All patients underwent extensive clinical workup (lab, brain MR, duplex sonography, 24-hour ECG,
transesophageal echocardiography) to exclude other causes of ischemic stroke. Prevalence of American Heart
Association lesion type VI (AHA-LT6), status of the fibrous cap, presence of hemorrhage/thrombus and area
measurements of calcification, necrotic core and hemorrhage were determined in both carotid arteries in
consensus by two reviewers who were blinded to clinical information. McNemar and Wilcoxon's signed rank tests
were use for statistical comparison. A p-value <0.05 was considered statistically significant.
Results: Symptomatic plaques showed a higher prevalence of AHA-LT6 (67.7% vs. 11.8%; p < 0.001; odds ratio = 12.5),
ruptured fibrous caps (44.1% vs. 2.9%; p < 0.001; odds ratio = 15.0), juxtaluminal thrombus (26.5 vs. 0%; p < 0.01; odds
ratio = 7.3) and intraplaque hemorrhage (58.6% vs. 11.8%; p = 0.01; odds ratio = 3.8). Necrotic core and hemorrhage
areas were greater in symptomatic plaques (14.1 mm2 vs. 5.5 mm2 and 13.6 mm2 vs. 5.3 mm2; p < 0.01, respectively).
Conclusion: 3 T bb-CMR is able to differentiate between symptomatic and asymptomatic carotid plaques,
demonstrating the potential of bb-CMR to differentiate between stable and vulnerable lesions and ultimately to
identify patients with low versus high risk for cardiovascular complications. Best predictors of the symptomatic side
were a ruptured fibrous cap, AHA-LT 6, juxtaluminal hemorrhage/thrombus, and intraplaque hemorrhage.
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Atherosclerotic disease and its complications are the
leading cause of death in the industrial world [1,2].
Increasing effort has been put into advancing diagnostic
and therapeutic options to better assess prognostic factors
and to improve treatment of cardiovascular atherosclerotic* Correspondence: tobias.saam@med.lmu.de
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reproduction in any medium, provided the ordisease. A crucial part in reducing the mortality of patients
suffering from atherosclerotic disease is an early reliable
diagnosis and a prognostic risk assessment regarding
cardiovascular incidents like infarction of heart muscle or
brain tissue. Recent investigations have led to the hypothesis
that composition and morphology of atherosclerotic plaques
are good predictors for risk of cardiovascular incidents,
rather than vascular stenosis alone [3-7].
A wide range of diagnostic methods like ultrasound,
CT angiography and cardiovascular magnetic resonance
(CMR) are currently in use to detect and characterizeLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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one of the most promising techniques. It is non-invasive
and - with 3 T scanners becoming widely available -
delivers excellent high resolution plaque images. More
specifically, plaque morphology and components can
reliably be identified and quantified, with excellent
correlation to histopathology [3,8-14].
In vivo CMR plaque characterization at high detail has
become a tool to investigate the relationship of certain
plaque features with clinical symptoms. An increasing
number of studies have addressed this issue, hypothesizing
that certain plaque features like intraplaque hemorrhage,
rupture of the fibrous cap, ulceration of plaque surface and
formation of thrombi at the plaque surface are associated
with cerebrovascular incidents [10,15-18].
However, most of these studies, except the study by
De Marco Ota et al. 2010, were performed at 1.5 T MR
scanners, scan times were relatively long (up to 45 mi-
nutes) and the number of excluded subjects was up to
32.5% [17-19], impeding its use in routine clinical stud-
ies. Furthermore, the time interval between symptom
onset and CMR examination in most studies with up to
3 months was relatively long [15,17] and results have to
be interpreted with caution, as plaque composition might
have changed during this time. In addition, definition
of symptomatic carotid disease varied wildly, e.g. many
studies did not use brain MR to confirm ischemic events
and TIA patients and patients with amaurosis fugax were
also included.
The purpose of this prospective monocentric observa-
tional study was to determine if high-resolution 3 T
magnetic resonance imaging with parallel imaging
techniques can depict differences between symptomatic
and asymptomatic carotid atherosclerotic plaques in acutely
symptomatic macroangiopathic ischemic stroke patients
referred from our interdisciplinary stroke center.
Method
This study was in accordance with local regulatory
legislation and approved by the institutional review
board. All subjects gave written informed consent before
CMR. The methods used in the study were in accordance
with the ethical standards laid down in the Declarations
of Helsinki.
Patients
36 consecutive patients from the stroke unit of the
Ludwig-Maximilians-University Hospital in Munich with
unilateral acute symptomatic carotid disease were included
in this study. Inclusion criteria were an ischemic stroke in
the territory of the anterior or middle cerebral artery <10
days before black-blood carotid CMR and ≥30% carotid
stenosis as determined by ultrasound according to the
NASCET criteria [20]. Ischemic stroke was defined as anacute lesion on diffusion weighted brain MR images (DWI)
and corresponding acute neurological deficit of more
than 24 hours duration. The symptomatic artery was
defined as being ipsilateral to the DWI lesion. Exclusion
criteria were bilateral infarcts on brain MR, known
contraindications against CMR, allergy to contrast
material, impaired renal function defined as a glomerular
filtration rate <30 ml/min, previous radiation therapy to
head or neck and a surgical procedure within 24 h before
black-blood carotid CMR.
All patients were subjected to the following investigations:
laboratory analysis (including electrolytes, differential blood
count, coagulation studies, and C-reactive protein), 12-lead
electrocardiography, Holter monitoring, transthoracic
echocardiography and/or transesophageal echocardiography
(TEE), duplex sonography of the extracranial vessels,
transcranial Doppler sonography, carotid black-blood
CMR and brain MR (including DWI sequences). The aortic
arch was evaluated for the presence of atherosclerotic
plaques by using TEE; in addition, CT angiography
(including the aortic arch) was available in the majority of
patients. Additional tests (e.g., cerebrospinal fluid analysis,
conventional angiography, screening for prothrombotic
conditions) were performed if clinically indicated. Based
on the results, patients were grouped according to the
TOAST (Trial of Org 10172 in Acute Stroke Treatment)
classification [21]. According to the TOAST classification,
ischemic strokes of 24 patients with ≥50% stenosis were
categorized into subtype I (large artery atherosclerosis)
and 8 patients with ≥30% but <50% stenosis were
categorized into subtype V (stroke of undetermined
etiology). Demographics and cardiovascular risk factors like
body mass index (BMI), present or past nicotine abuse,
hypertension, diabetes mellitus, hypercholesterolemia and
coronary heart disease (CHD) as well as family history of
CHD were recorded.
MR imaging protocol
All subjects underwent a carotid black-blood high
resolution CMR at 3 T on a Siemens Verio Scanner
(Siemens AG, Erlangen, Germany) using dedicated
surface coils (Machnet, Elde, Netherlands) and a previously
published multi-sequence protocol [22] (time-of-flight
MR angiography (TOF), axial fat suppressed pre- and
post- contrast black-blood T1-, PD- and T2- weighted
sequences; best in-plane resolution 0.5 × 0.5 mm2). Each
scan covered 30 mm (2 mm slice thickness × 15 matched
images across the 5 sequences). This coverage is usually
sufficient to image the complete carotid atherosclerotic
plaque [23]. Parallel imaging based on the generalized
auto calibrating partially parallel acquisition (GRAPPA)
algorithm was used for all sequences with a parallel
acquisition technique (PAT) acceleration factor of 2.
Total imaging time was 17:43 minutes. Gadobutrol
Table 1 Clinical data
Parameter Value [n = 34 patients]
Age ± 1 SD [years] 70 ± 9.3
Male [%] (n) 71% (24)
Mean Body Mass Index ± 1 SD 25.8
Risk factors
Hypercholesterolemia/Hyperlipidemia [%] (n) 53% (18)
Arterial hypertension [%] (n) 62% (21)
Active nicotine abuse [%] (n) 26% (9)
Former nicotine abuse [%] (n) 35% (12)
Diabetes mellitus [%] (n) 18% (6)
CHD or CVD [%] (n) 18% (6)
Family history of CHD or CVD [%] (n) 29% (10)
* McNemar Test; SD = Standard Deviation; CHD = Coronary Heart Disease;
CVD = Cerebrovascular Disease (TIA or Stroke).
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0.1 mmol/kg (0.1 ml/kg) was given at a rate of 3 mL/s.
Post-contrast T1w imaging was performed approximately
5 minutes after intravenous injection of the contrast agent.
Image analysis
An image-quality rating (4-point scale, 1 = non diagnostic,
2 = poor, 3 = good, 4 = excellent) was assigned to all
MR images. MR data was reviewed by two experienced
radiologists with 11 (T.S.) and 4 years (J.M.G.) experience
in carotid CMR who were blinded to the brain MR and to
all clinical information of the patient. The initial review
was done by J.M.G. and the final review by T.S. who was
aware of the assessment of the initial review. In case of
discrepancy, a consensus decision was made. Examinations
with an image quality ≤ 2 were excluded from the study.
Atherosclerotic plaques in the carotid arteries (on both
the ipsilateral and contralateral side) were recorded and
classified according to the modified criteria of the
American Heart Association [24]. Tissue components
(necrotic core, calcification, hemorrhage, loose matrix)
and type and location of hemorrhage were identified and
quantified based on previously published criteria
[3,8,25,26]. For definition of a complicated AHA-LT6
plaque, at least one of the following three criteria was
required: Fibrous cap rupture, intraplaque hemorrhage,
juxtaluminal hemorrhage/mural thrombus. Area measure-
ments of the lumen, outer wall, and tissue components
were obtained using the custom-designed image analysis
tool CASCADE (University of Washington, Seattle, US)
[27]. The “total vessel area” included the lumen and wall
areas. The wall area for each location was calculated as the
difference between the total vessel and lumen areas. The
normalized wall index (NWI) was calculated by dividing
the wall area by the total vessel area.
Statistical analysis
Each patient contributed only one set of observations
(one study of the symptomatic artery, one study of the
asymptomatic arteries) to the data set for analysis. Area
measurements for each artery were calculated as the
minimum and maximum areas for each artery separately.
Categorical variables are presented as relative and absolute
frequencies, while continuous variables are presented as
mean and standard deviation. Wilcoxon’s signed rank test
was used to test differences for continuous variables, and
the McNemar test was used to determine differences be-
tween categorical variables. We also derived the relative risk
(odds ratio, OR) associated with AHA-LT6, intraplaque
hemorrhage, juxtaluminal hemorrhage/thrombus, and a
ruptured fibrous cap as determined by CMR for the
presence of symptoms using conditional logistic regression
analysis taking into account the clustered data structure
per subject. A p-value <0.05 was considered statisticallysignificant. Analyses were carried out using SPSS 16.0 for
Windows (International Business Machines Corp., New
York, USA) and SAS 9.2 (Cary, NC).
Results
Image quality
In 34 out of 36 patients (94.4%) image quality of CMR
examinations was sufficient (≥ 2) to be included in the
study with a mean image quality rating of 3.8. All data in
this evaluation is based on these 34 patients. Two patients
had to be excluded due to severe motion artifacts.
Demographics and clinical data
Clinical data of the 34 included patients are displayed in
Table 1. An overview of the imaging results is given in
Table 2, ORs with 95% confidence intervals are summarized
in Table 3. An imaging example is given in Figure 1.
Prevalence of plaque features ipsilateral and contralateral
to ischemic stroke
In the qualitative analysis, symptomatic plaques had a
higher prevalence of AHA-LT6 compared to asymptomatic
plaques (67.6% vs. 11.8%; p < 0.001; OR = 12.5), while in
asymptomatic plaques AHA-LT3 and 7 were more frequent
(14.7% vs. 0% and 20.6% vs. 2.9%; p < 0.05, respectively)
[Figure 2]. A ruptured fibrous cap was found more fre-
quently in the symptomatic than in the asymptomatic
group (44.1% vs. 2.9%; p < 0.001; OR = 15.0). Prevalence of
haemorrhage (intraplaque haemorrhage and juxtaluminal
haemorrhage/thrombus combined) was significantly higher
in the symptomatic group (67.7% vs. 11.8%; p < 0.001). Sev-
eral patients had a combination of intraplaque hemorrhage
and juxtaluminal hemorrhage/thrombus. More specifically,
prevalence of intraplaque hemorrhage was 58.6% in
the symptomatic group and 11.8% in the asymptomatic
group (p < 0.01; OR = 3.8). Juxtaluminal hemorrhage
Table 2 CMR data
Symptomatic plaques (n = 34 arteries) Asymptomatic plaques (n = 34 arteries) p-value*
Mean lumen area [mm2] 24.9 ± 11.1 26.7 ± 11.3 n.s.
Mean wall area [mm2] 43.0 ± 13.0 35.9 ± 10.2 0.04
Normalized wall index 0.66 ± 0.1 0.59 ± 0.1 n.s.
Mean total vessel area [mm2] 67.9 ± 21.4 62.5 ± 17.7 n.s.
Area measurements of plaque components
Max. necrotic core, [mm2] 14.1 ± 9.7 5.5 ± 7.5 0.001
Max. intraplaque hemorrhage, [mm2] 8.0 ± 9,3 1.3 ± 7.5 0.007
Max. loose matrix, [mm2] 0.7 ± 2.1 1.0 ± 3.2 n.s.
Max. calcification, [mm2] 2.2 ± 3.3 2.4 ± 3.8 n.s.
Plaque components as percentage of the vessel wall (in%)
Max. necrotic core, [%] 25.9 ± 14.6 11.2 ± 13.3 0.001
Max. intraplaque hemorrhage, [%] 14.3 ± 19.9 2.2 ± 6.7 0.003
Max. loose matrix, [%] 1.6 ± 4.1 1.7 ± 5.0 n.s.
Max. Calcification, [%] 4.1 ± 5.5 5.1 ± 6.1 n.s.
Prevalence of plaque features
Juxtaluminal hemorrhage/thrombus [%] (n) 26.5% (9) 0 <0.01
Intraplaque hemorrhage [%] (n) 58.6% (20) 11.8% (4) <0.01
Any hemorrhage [%] (n) 67.6% (23) 11.8% (4) <0.001
Ruptured fibrous cap [%] (n) 44.1% (15) 2.9% (1) <0.001
Necrotic core [%] (n) 94.1% (32) 55.8% (19) <0.001
Calcification [%] (n) 52.9% (18) 55.8% (19) n.s.
American heart association (AHA) lesion type
Type I [%] (n) 0 11.8% (4) n.s.
Type III [%] (n) 0 14.7% (5) 0.02
Type IV/V [%] (n) 29.4% (10) 41.2% (14) n.s.
Type VI [%] (n) 67.6% (23) 11.8% (4) <0.001
Type VII [%] (n) 2.9% (1) 20.6% (7) 0.03
Type VIII [%] (n) 0 0 n.s.
* McNemar test or Wilcoxon Signed Rank test; Values are given as mean ± Standard Deviation.
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in the symptomatic group (26.5% vs. 0%; p < 0.01;
OR = 7.3).
Plaques showed a necrotic core more frequently in the
symptomatic than in the asymptomatic group (94.1% vs.
55.8%; p < 0.001). In contrast, prevalence of intraplaque
calcification was not significantly different between theTable 3 Odds ratios of qualitative CMR variables for the
presence of symptoms
Variable Odds ratio (95% CI)
Intraplaque hemorrhage 3.75 (1.2 – 11.3)
Juxtaluminal hemorrhage/thrombus 7.3 (2.2 – 24.5)
Ruptured fibrous cap 15.0 (2.0 – 113.6)
AHA lesion type VI 12.5 (3.0 – 52.8)
CI Confidence Interval, AHA American Heart Association.symptomatic and asymptomatic group (52.9% vs. 55.8%;
p = 0.81).
Quantitative plaque characteristics ipsilateral and
contralateral to ischemic stroke
In the quantitative analysis [Figure 3], maximum necrotic
core and intraplaque hemorrhage area were greater in
symptomatic than in asymptomatic plaques (14.1 mm2 vs.
5.5 mm2 and 8.0 mm2 vs. 1.3 mm2; p < 0.01, respectively),
while mean vessel and lumen areas did not significantly
differ between both groups. Mean wall area was greater in
the symptomatic group (43.0 vs. 35.9 mm2; p = 0.04).
Effect of the TOAST classification and demographics on
qualitative and quantitative plaque characteristics
No significant differences in the prevalence of compli-










Figure 1 Imaging example. Figure 1 shows various CMR-images of a 66 years old patient who suffered an infarction 4 days before the CMR
scan. a. T1w and DWI MR-images of the patient. Axial T1w images with fat suppression demonstrate atherosclerotic lesions in both internal
carotid arteries (ICA). The lesion in the right ICA, ipsilateral to the symptoms, is hyperintense, consistent with intraplaque hemorrhage. The lesion
in the left ICA is hypo- to isointense, consistent with a fibrous and calcified lesion. Axial DWI images show a diffusion restriction in the posterior
part of the right middle cerebral artery, consistent with an acute brain infarction. b. Axial multi-sequence CMR images of the same patient
demonstrating the complicated AHA lesion type VI plaque ipsilateral to the stroke in the right ICA. The arrow points to a region which is
hyperintense on T1w and TOF images and hypointense on PDw and T2w images, consistent with type I hemorrhage into a large necrotic core.
The dark band on TOF images is disrupted, the hyperintense area on TOF is located juxtaluminally and the fibrous cap cannot be visualized in
the contrast enhanced T1w images, indicating rupture of the fibrous cap (ICA = Internal carotid artery, TOF = Time-of-Flight). c. Axial multi-
sequence CMR images of the same patient demonstrating the uncomplicated AHA lesion type VII plaque contralateral to the stroke in the left
ICA. The arrow points to a region which is hypointense on all images, consistent with a calcification, surrounding an area which is isointense to
fatty tissue in T1w, T2w and PDw images and shows no contrast enhancement, consistent with a necrotic lipid core. The contrast enhancing
fibrous cap separating the plaque from the lumen appears intact. (ICA = Internal carotid artery, TOF = Time-of-Flight).
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Figure 2 Distribution of AHA lesion type. Figure 2 visualizes the distribution of AHA lesion types in the asymptomatic and the symptomatic
groups. Note the higher prevalence of AHA lesion type 6 plaques in the symptomatic group and of types 3 and 7 in the asymptomatic group.
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etiology according to TOAST) and the 24 patients
with ≥50% stenosis (50% vs. 71%, p = 0.4). No other
significant differences were found.
Discussion
Findings of our study demonstrated that 3 T high resolution
in vivo CMR using parallel imaging and dedicated
surface coils is a reliable, fast and robust technique,
which allows to non-invasively depict significant differences
between symptomatic and asymptomatic carotid plaques in
patients with acute ischemic stroke.
In our study we aimed to eliminate limitations of
previous examinations and to determine if high-resolution






















* P < 0.01
Figure 3 Quantitative analysis of plaque components. Figure 3 shows
mm2 on cross sectional images for symptomatic and asymptomatic plaque
cross sectional area for lipid rich necrotic cores and hemorrhage while notechniques can depict differences between symptomatic
and asymptomatic carotid atherosclerotic plaques in pa-
tients with acute ischemic stroke. Existing studies, for ex-
ample, were mainly performed on 1.5 T CMR scanners
[17-19] and no Parallel Imaging techniques were used
[15,17-19,28]. While in most studies the number of ex-
cluded subjects was relatively large with 15% [17], 19%
[18,28] and 32.5% [19], only 5.6% (2 out of 34) of our pa-
tients had to be excluded due to insufficient image
quality in our study. A 3 T-CMR study of Demarco et al.
[15] excluded 7.2% of patients, but included only 13
symptomatic patients and was not correlated with
diffusion weighted MR. Also, the interval between
symptom onset and CMR was longer in some studies







the absolute quantitative distribution of different plaque features in
s in comparison. Symptomatic plaques showed a greater maximum
differences were found for loose matrix and calcification areas.
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of patients suffering from acute unilateral ischemic stroke
using high resolution 3 T in vivo plaque imaging with
Parallel Imaging techniques and dedicated surface coils.
The MR imaging protocol used in our study as described
by Saam et al. [22] took only 17:43 minutes and was thus
considerably shorter than some of the protocols used in
other studies with around 22 minutes reported by Demarco
et al. [15] and approximately 40 minutes in the study by
Boussels [19]. The shorter acquisition time in combination
with the higher field strength might be the main reason for
the relatively low exclusion rate observed in our study. One
potential advantage of our imaging platform which was not
explored in our study is the potential to perform the brain
MR and the carotid CMR in the same imaging session
without the necessity to change the coils. This approach
could help to establish carotid plaque CMR as a useful
clinical tool in patients with acute ischemic stroke.
High resolution in vivo 3 T black blood CMR using
dedicated surface coils and Parallel Imaging techniques can
depict differences between symptomatic and asymptomatic
plaques and thus differentiate between symptomatic and
asymptomatic lesions as suggested by previous studies. The
most potent single predictor for the symptomatic side in
our study was a ruptured fibrous cap with an OR of 15.0
(95% CI = 2.0 – 113.6). An AHA lesion type VI and
juxtaluminal thrombus were slightly inferior predic-
tors with ORs of 12.5 (95% CI = 3.0 – 52.8) and 7.3
(95% CI = 2.2 – 24.5), respectively, while intraplaque
hemorrhage had the lowest OR (3.75; 95% CI = 1.2–11.3).
Therefore, it seems to be important to apply MR sequences,
which can detect a rupture of the fibrous cap as well
as intraplaque hemorrhage and juxtaluminal hemorrhage/
thrombus in order to assess plaque vulnerability. Findings
of our study are consistent with a study by Parmar et al.
[18], which included 78 patients with 40 TIAs/strokes.
Demarco et al. [15] recently published a study at 3 T
with 13 symptomatic and 77 asymptomatic subjects. The
plaque features that showed the highest association with
symptoms differed between subjects with moderate and
severe stenosis. In patients with severe carotid stenosis
ulceration on MRA demonstrated the strongest association
with symptoms with an OR of 10.5, while in patients with
moderate stenosis presence of intraplaque hemorrhage
showed the strongest association with symptoms with an
OR of 6.0. Interestingly, intraplaque hemorrhage was not
significantly associated with symptoms in patients with
severe carotid stenosis (OR = 1.3).
In our study we found a slightly higher prevalence of
AHA lesion Type VI in plaques with carotid stenosis ≥50%
compared to plaques with 30-49% stenosis. Findings of a
previously published study with 192 patients showed an
increasing prevalence of AHA lesion type VI with increas-
ing degree of stenosis in asymptomatic subjects [29]. Whileour results point in the same direction, they do not fully
confirm these findings, which may be attributed to the
smaller number of patients in our study. We did not find a
higher prevalence of AHA lesion type VI in male compared
to female patients. This was proposed in a previous report
by Ota et al. (Stroke 2010) with 131 asymptomatic patients
(men, 67; women, 64) with ≥50% carotid stenosis on duplex
ultrasound showing a higher prevalence of a ruptured
fibrous cap (48% versus 17%, adjusted OR = 4.41, p < 0.01)
and lipid-rich necrotic core (73% versus 50%, adjusted
OR = 3.66, p = 0.01) in men as well as a trend for higher
prevalence of hemorrhage (33% versus, 17%, adjusted OR=
2.15, p = 0.07) in men. However, this study included only
asymptomatic patients and our study suggests that these
findings cannot be applied in symptomatic populations.
Limitations
Although we found highly significant differences between
symptomatic and asymptomatic plaques, there was a
significant overlap of some of these plaque features between
symptomatic and asymptomatic plaques, suggesting that a
complete separation of symptomatic and asymptomatic
subjects is not feasible using a single CMR variable. This
limitation might be overcome by using a scoring system
based on a number of variables, such as previously pro-
posed by Gury-Paquet et al.[28]or Underhill et al. [29].
Conclusion
Our results confirm that 3 T high resolution in vivo CMR
using parallel imaging and dedicated surface coils is a
potent and fast tool in the assessment of carotid athero-
sclerotic disease and could be easily implemented into the
clinical routine with a scan time of <25 minutes. The
imaging procedure is robust, yielding an image quality that
is sufficient for detailed plaque assessment in the vast
majority of cases. In our study, a ruptured fibrous cap was
the dominant outcome-associated observation achieving
significance with an OR of 15.0. Prevalence of a compli-
cated AHA lesion type VI, which is characterized by
hemorrhage, thrombus or a ruptured fibrous cap, was a
comparably potent predictor for the symptomatic side with
an OR of 12.5. In the future, prospective studies will have
to determine the predictive value of AHA lesion type VI in
general and a ruptured fibrous cap in particular on cerebro-
vascular symptoms. One currently on-going study started
in February 2011 is the CAPIAS trial (Carotid Plaque
Imaging in Acute Ischemic Stroke; ClinicalTrials.gov
Identifier: NCT01284933), which evaluates the preva-
lence and effects of AHA lesion type VI in patients with
acute ischemic stroke and <70% stenosis. Findings of the
CAPIAS study will provide valuable insights into stroke
mechanisms and could be the basis for planning targeted
interventional studies, which could focus on a combination
of plaque morphology and the degree of luminal stenosis.
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